Pharmafile Logo
Pharmafocus logo
Advanced Search

P&G

Showing 6 posts of 6 posts found.

merck_kgaa_pyramid_use_with_credit

Merck KGaA finds consumer health buyer in P&G for €3.4bn

April 19, 2018
Sales and Marketing Merck KGaA, P&G, Pfizer, biotech, drugs, pharma, pharmaceutical

Merck KGaA has successfully found a buyer for its healthcare unit, after Proctor & Gamble announced that it was prepared …

News
pfizer_chrome_plate

Pfizer running out of options for consumer business

April 4, 2018
Research and Development, Sales and Marketing P&G, Pfizer, Procter & Gamble, biotech, drugs, pharma, pharmaceutical

A surprise new name was thrown into the ring to take on Pfizer’s healthcare unit but speculation suggests that valuation …

News

CSL vaccine plant cited in FDA letter

July 1, 2010
Manufacturing and Production CSL, GMP, P&G, manufacturing compliance

CSL Biotherapies has been sent a letter by the US Food and Drug Administration which indicates that vials of seasonal …

News

Warner Chilcott sees major jump in revenue

March 2, 2010
P&G, Warner Chilcott

Warner Chilcott saw a big increase in 2009 revenue thanks to its acquisition of Proctor and Gamble’s branded pharmaceuticals business. …

News
Blog footer

Digital Pharma – Byte-sized roundup

January 22, 2010
Medical Communications Fresenius Kabi, P&G, Prilosec OTC, Seroquel, Twitter, digital pharma

In this week’s roundup: P&G taps social media for Prilosec OTC, UK launches new data site, analysis of pharma on …

News

Warner Chilcott buys P&G pharma for $3.1 billion

August 25, 2009
Research and Development, Sales and Marketing MA, P&G, Warner Chilcott

Specialist pharma company Warner Chilcott is to buy Procter & Gamble's pharmaceutical division for $3.1 billion, turning it into a …

News

Latest content

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024

FDA approves ImmunityBio’s Anktiva bladder cancer treatment

April 23, 2024

EC approves Pfizer’s Emblaveo for multidrug-resistant infection treatment

April 22, 2024

Neurolentech and Kaerus Bioscience enter partnership for research on neurodevelopmental disorder

April 22, 2024

Ardena announces €20m expansion following first GMP approval

April 19, 2024